vs
RCI HOSPITALITY HOLDINGS, INC.（RICK）与Vericel Corp（VCEL）财务数据对比。点击上方公司名可切换其他公司
Vericel Corp的季度营收约是RCI HOSPITALITY HOLDINGS, INC.的1.3倍（$92.9M vs $70.9M），Vericel Corp净利率更高（25.0% vs -7.8%，领先32.8%），Vericel Corp同比增速更快（23.3% vs -3.1%），Vericel Corp自由现金流更多（$12.8M vs $11.5M），过去两年Vericel Corp的营收复合增速更高（34.6% vs -2.0%）
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
Vericel Corp是一家美国上市生物制药企业，前身为1989年在密歇根州安娜堡成立的Aastrom Bio，2014年10月正式更为现名，专注于生物制药相关领域的研发与商业化运营。
RICK vs VCEL — 直观对比
营收规模更大
VCEL
是对方的1.3倍
$70.9M
营收增速更快
VCEL
高出26.4%
-3.1%
净利率更高
VCEL
高出32.8%
-7.8%
自由现金流更多
VCEL
多$1.3M
$11.5M
两年增速更快
VCEL
近两年复合增速
-2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $70.9M | $92.9M |
| 净利润 | $-5.5M | $23.2M |
| 毛利率 | — | 78.7% |
| 营业利润率 | -0.7% | 24.1% |
| 净利率 | -7.8% | 25.0% |
| 营收同比 | -3.1% | 23.3% |
| 净利润同比 | -2354.9% | 17.3% |
| 每股收益（稀释后） | $-0.60 | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RICKVCEL
| Q4 25 | — | $92.9M | ||
| Q3 25 | $70.9M | $67.5M | ||
| Q2 25 | $71.1M | $63.2M | ||
| Q1 25 | $65.9M | $52.6M | ||
| Q4 24 | $71.5M | $75.4M | ||
| Q3 24 | $73.2M | $57.9M | ||
| Q2 24 | $76.2M | $52.7M | ||
| Q1 24 | $72.3M | $51.3M |
净利润RICKVCEL
| Q4 25 | — | $23.2M | ||
| Q3 25 | $-5.5M | $5.1M | ||
| Q2 25 | $4.1M | $-553.0K | ||
| Q1 25 | $3.2M | $-11.2M | ||
| Q4 24 | $9.0M | $19.8M | ||
| Q3 24 | $244.0K | $-901.0K | ||
| Q2 24 | $-5.2M | $-4.7M | ||
| Q1 24 | $774.0K | $-3.9M |
毛利率RICKVCEL
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 68.9% |
营业利润率RICKVCEL
| Q4 25 | — | 24.1% | ||
| Q3 25 | -0.7% | 5.1% | ||
| Q2 25 | 12.2% | -3.2% | ||
| Q1 25 | 12.4% | -24.3% | ||
| Q4 24 | 19.5% | 24.5% | ||
| Q3 24 | 4.8% | -4.3% | ||
| Q2 24 | -3.3% | -11.5% | ||
| Q1 24 | 6.4% | -10.7% |
净利率RICKVCEL
| Q4 25 | — | 25.0% | ||
| Q3 25 | -7.8% | 7.5% | ||
| Q2 25 | 5.7% | -0.9% | ||
| Q1 25 | 4.9% | -21.4% | ||
| Q4 24 | 12.6% | 26.3% | ||
| Q3 24 | 0.3% | -1.6% | ||
| Q2 24 | -6.9% | -8.9% | ||
| Q1 24 | 1.1% | -7.5% |
每股收益（稀释后）RICKVCEL
| Q4 25 | — | $0.46 | ||
| Q3 25 | $-0.60 | $0.10 | ||
| Q2 25 | $0.46 | $-0.01 | ||
| Q1 25 | $0.36 | $-0.23 | ||
| Q4 24 | $1.01 | $0.40 | ||
| Q3 24 | $0.04 | $-0.02 | ||
| Q2 24 | $-0.56 | $-0.10 | ||
| Q1 24 | $0.08 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.7M | $137.5M |
| 总债务越低越好 | $238.2M | — |
| 股东权益账面价值 | $261.1M | $354.6M |
| 总资产 | $596.9M | $488.0M |
| 负债/权益比越低杠杆越低 | 0.91× | — |
8季度趋势，按日历期对齐
现金及短期投资RICKVCEL
| Q4 25 | — | $137.5M | ||
| Q3 25 | $33.7M | $135.4M | ||
| Q2 25 | $29.3M | $116.9M | ||
| Q1 25 | $32.7M | $112.9M | ||
| Q4 24 | $34.7M | $116.2M | ||
| Q3 24 | $32.4M | $101.7M | ||
| Q2 24 | $34.9M | $102.5M | ||
| Q1 24 | $20.0M | $110.6M |
总债务RICKVCEL
| Q4 25 | — | — | ||
| Q3 25 | $238.2M | — | ||
| Q2 25 | $243.8M | — | ||
| Q1 25 | $244.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $241.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益RICKVCEL
| Q4 25 | — | $354.6M | ||
| Q3 25 | $261.1M | $321.9M | ||
| Q2 25 | $269.5M | $306.8M | ||
| Q1 25 | $268.8M | $295.5M | ||
| Q4 24 | $269.0M | $292.0M | ||
| Q3 24 | $263.4M | $257.5M | ||
| Q2 24 | $271.2M | $243.0M | ||
| Q1 24 | $285.8M | $233.9M |
总资产RICKVCEL
| Q4 25 | — | $488.0M | ||
| Q3 25 | $596.9M | $453.3M | ||
| Q2 25 | $597.4M | $435.6M | ||
| Q1 25 | $589.8M | $424.6M | ||
| Q4 24 | $586.2M | $432.7M | ||
| Q3 24 | $584.4M | $390.4M | ||
| Q2 24 | $601.0M | $376.8M | ||
| Q1 24 | $609.9M | $356.7M |
负债/权益比RICKVCEL
| Q4 25 | — | — | ||
| Q3 25 | 0.91× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.7M | $15.0M |
| 自由现金流经营现金流 - 资本支出 | $11.5M | $12.8M |
| 自由现金流率自由现金流/营收 | 16.2% | 13.8% |
| 资本支出强度资本支出/营收 | 3.2% | 2.4% |
| 现金转化率经营现金流/净利润 | — | 0.65× |
| 过去12个月自由现金流最近4个季度 | $34.9M | $24.7M |
8季度趋势，按日历期对齐
经营现金流RICKVCEL
| Q4 25 | — | $15.0M | ||
| Q3 25 | $13.7M | $22.1M | ||
| Q2 25 | $13.8M | $8.2M | ||
| Q1 25 | $8.5M | $6.6M | ||
| Q4 24 | $13.3M | $22.2M | ||
| Q3 24 | $15.7M | $10.2M | ||
| Q2 24 | $15.8M | $18.5M | ||
| Q1 24 | $10.8M | $7.2M |
自由现金流RICKVCEL
| Q4 25 | — | $12.8M | ||
| Q3 25 | $11.5M | $19.5M | ||
| Q2 25 | $10.1M | $81.0K | ||
| Q1 25 | $5.7M | $-7.6M | ||
| Q4 24 | $7.6M | $8.5M | ||
| Q3 24 | $10.3M | $-9.2M | ||
| Q2 24 | $9.3M | $1.8M | ||
| Q1 24 | $3.2M | $-6.8M |
自由现金流率RICKVCEL
| Q4 25 | — | 13.8% | ||
| Q3 25 | 16.2% | 28.8% | ||
| Q2 25 | 14.2% | 0.1% | ||
| Q1 25 | 8.6% | -14.5% | ||
| Q4 24 | 10.6% | 11.2% | ||
| Q3 24 | 14.0% | -15.9% | ||
| Q2 24 | 12.3% | 3.4% | ||
| Q1 24 | 4.4% | -13.3% |
资本支出强度RICKVCEL
| Q4 25 | — | 2.4% | ||
| Q3 25 | 3.2% | 3.9% | ||
| Q2 25 | 5.2% | 12.9% | ||
| Q1 25 | 4.3% | 27.0% | ||
| Q4 24 | 8.0% | 18.3% | ||
| Q3 24 | 7.3% | 33.5% | ||
| Q2 24 | 8.4% | 31.8% | ||
| Q1 24 | 10.6% | 27.3% |
现金转化率RICKVCEL
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | 3.40× | — | ||
| Q1 25 | 2.65× | — | ||
| Q4 24 | 1.48× | 1.12× | ||
| Q3 24 | 64.14× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 14.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
